Zinc / TumCI Cancer Research Results

Z, Zinc: Click to Expand ⟱

Features:

Zinc (Zn²⁺) — essential trace element; structural/catalytic cofactor for >300 enzymes and ~10% of the human proteome (zinc-finger transcription factors). Obtained from diet/supplements (e.g., zinc gluconate, acetate, sulfate).

Primary mechanisms (conceptual rank):
1) Metalloprotein cofactor / transcriptional regulation (zinc-finger domains; p53 structural integrity)
2) Redox buffering & signaling modulation (indirect antioxidant; NADPH oxidase/SOD context)
3) Immune regulation (T-cell function; cytokine tone)
4) Apoptosis / mitochondrial signaling (dose-dependent)
5) Synaptic neuromodulation (brain Zn²⁺ pools; excitability)

Bioavailability / PK relevance: Tight homeostatic control (ZIP/ZnT transporters; metallothioneins). Oral absorption varies with form and dietary phytates; systemic free Zn²⁺ remains low (nanomolar). Many in-vitro cytotoxic effects use supra-physiologic micromolar levels.

In-vitro vs oral exposure: Direct tumor cytotoxicity typically at high concentrations (qualifier: high concentration only). Physiologic supplementation mainly corrects deficiency.

Clinical evidence status: Established for deficiency and immune support; oncology data mixed/observational; no stand-alone anti-cancer approval.

Zinc is an essential mineral that supports immune function, wound healing, skin health, and more.

Zinc is an essential cofactor for many enzymes, including superoxide dismutase (SOD), which scavenges free radicals and limits oxidative stress—a known contributor to DNA damage and cancer initiation.

Maintaining adequate zinc status (typically, serum concentrations within a normal reference range of roughly 70–120 µg/dL) is important for overall health, while both deficiency and excessive intake may have implications for cancer risk.

Some zinc-dependent enzymes, such as histone deacetylases (HDACs) or components of chromatin remodeling complexes, rely on zinc for their function.

Zinc can modulate several intracellular signaling cascades. For example, zinc ions may affect the activity of protein kinases and phosphatases.

Evidence suggests that alterations in zinc levels can impact growth factor signaling pathways, which are vital in controlling cell growth and survival and are often dysregulated in cancer.

Zinc is involved in the regulation of cell cycle progression and apoptosis (programmed cell death). It can modulate the activity of several transcription factors (e.g., p53) that regulate growth arrest and apoptosis in response to cellular stress.

Zinc (Zn²⁺) — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	p53 structural integrity (zinc-finger stabilization)	↑ (if WT p53; context-dependent)	↑	R/G	Tumor suppressor function support	Zinc required for proper p53 conformation; deficiency impairs DNA damage response.
2	ROS	↓ (physiologic); ↑ (high concentration only)	↓	P/R	Redox modulation	Indirect antioxidant via metallothionein/SOD; excess Zn²⁺ can induce oxidative stress.
3	NRF2 axis	↑ (mild; context-dependent)	↑	R/G	Stress-response activation	Zinc can induce metallothionein and antioxidant gene expression.
4	Apoptosis (mitochondrial; caspases)	↑ or ↓ (dose-dependent)	↔ / ↑ (excess)	R/G	Cell death modulation	Low physiologic levels protective; high intracellular Zn²⁺ may trigger apoptosis.
5	Immune signaling (NF-κB; cytokines)	↓ inflammatory tone (indirect)	↓ (balanced immune support)	R/G	Immune modulation	Deficiency elevates inflammation; repletion normalizes cytokine signaling.
6	PI3K/AKT	↔ / ↑ (context-dependent)	↔	R/G	Growth signaling influence	Zinc transporters (ZIP4, ZIP6) implicated in tumor progression; effect is transporter-context specific.
7	HIF-1α	↓ (some models)	↔	G	Hypoxia signaling modulation	Reported inhibitory interaction in certain tumor models.
8	Ferroptosis	↔ (limited evidence)	↔	R/G	Not primary axis	Indirect influence via redox state possible but not canonical driver.
9	Ca²⁺ signaling	↔ / competitive modulation	↔	P/R	Ion channel interaction	Zinc can modulate NMDA and other channels; more relevant in neurons than oncology.
10	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Tight homeostasis	Systemic Zn²⁺ tightly regulated; excess supplementation may cause copper deficiency and immune imbalance.

TSF legend:
P: 0–30 min (ion-channel/redox interactions)
R: 30 min–3 hr (signaling modulation)
G: >3 hr (gene-regulatory/phenotype outcomes)

AD relevance: Zinc plays a dual role in Alzheimer’s disease: essential for synaptic function and antioxidant defense, but dysregulated Zn²⁺ can promote amyloid aggregation and excitotoxic injury.

Primary mechanisms (conceptual rank):
1) Aβ aggregation modulation (Zn²⁺ binding to amyloid)
2) Synaptic Zn²⁺ signaling (NMDA modulation; plasticity)
3) Redox buffering (metallothionein induction)
4) Neuroinflammation modulation
5) Tau phosphorylation influence (indirect)

Clinical evidence status: Mixed; deficiency harmful, excess potentially detrimental. No consensus that supplementation benefits established AD unless deficient.

Zinc (Zn²⁺) — AD / Neurodegeneration Pathway Map

Rank	Pathway / Axis	Cells	TSF	Primary Effect	Notes / Interpretation
1	Aβ aggregation	↑ (excess); ↔ (physiologic)	G	Plaque stabilization potential	Zinc binds Aβ; high synaptic Zn²⁺ may promote aggregation.
2	Synaptic transmission (NMDA modulation)	↔ / modulated	P/R	Plasticity regulation	Vesicular Zn²⁺ co-released with glutamate; influences excitability.
3	ROS	↓ (physiologic); ↑ (excess)	P/R	Redox balance	Deficiency increases oxidative stress; overload promotes injury.
4	NRF2 / Metallothionein	↑ (adaptive)	R/G	Antioxidant defense	Metallothioneins buffer Zn²⁺ and reduce oxidative damage.
5	Neuroinflammation	↔ / ↓ (deficiency correction)	R/G	Immune balance	Optimal zinc supports immune regulation; imbalance may exacerbate inflammation.
6	Ca²⁺ excitotoxicity interplay	↔ / ↑ (excess)	P/R	Excitotoxic vulnerability	High Zn²⁺ can enter neurons and impair mitochondrial function.
7	Clinical Translation Constraint	↓ (constraint)	—	Homeostatic narrow range	Both deficiency and excess harmful; supplementation appropriate only if low.

TSF legend:
P: 0–30 min (synaptic ion effects)
R: 30 min–3 hr (signaling adaptation)
G: >3 hr (aggregation and phenotype changes)

TumCI, Tumor Cell invasion: Click to Expand ⟱

Source:

Type:

Tumor cell invasion is a critical process in cancer progression and metastasis, where cancer cells spread from the primary tumor to surrounding tissues and distant organs. This process involves several key steps and mechanisms:

1.Epithelial-Mesenchymal Transition (EMT): Many tumors originate from epithelial cells, which are typically organized in layers. During EMT, these cells lose their epithelial characteristics (such as cell-cell adhesion) and gain mesenchymal traits (such as increased motility). This transition is crucial for invasion.

2.Degradation of Extracellular Matrix (ECM): Tumor cells secrete enzymes, such as matrix metalloproteinases (MMPs), that degrade the ECM, allowing cancer cells to invade surrounding tissues. This degradation facilitates the movement of cancer cells through the tissue.

3.Cell Migration: Once the ECM is degraded, cancer cells can migrate. They often use various mechanisms, including amoeboid movement and mesenchymal migration, to move through the tissue. This migration is influenced by various signaling pathways and the tumor microenvironment.

4.Angiogenesis: As tumors grow, they require a blood supply to provide nutrients and oxygen. Tumor cells can stimulate the formation of new blood vessels (angiogenesis) through the release of growth factors like vascular endothelial growth factor (VEGF). This not only supports tumor growth but also provides a route for cancer cells to enter the bloodstream.

5.Invasion into Blood Vessels (Intravasation): Cancer cells can invade nearby blood vessels, allowing them to enter the circulatory system. This step is crucial for metastasis, as it enables cancer cells to travel to distant sites in the body.

6.Survival in Circulation: Once in the bloodstream, cancer cells must survive the immune response and the shear stress of blood flow. They can form clusters with platelets or other cells to evade detection.

7.Extravasation and Colonization: After traveling through the bloodstream, cancer cells can exit the circulation (extravasation) and invade new tissues. They may then establish secondary tumors (metastases) in distant organs.

8.Tumor Microenvironment: The surrounding microenvironment plays a significant role in tumor invasion. Factors such as immune cells, fibroblasts, and signaling molecules can either promote or inhibit invasion and metastasis.

Scientific Papers found: Click to Expand⟱

961-

Zinc Downregulates HIF-1α and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo

in-vitro,

RCC,

RCC4

vitro+vivo,

GBM,

U373MG

in-vitro,

Nor,

HUVECs

Hif1a↓, HIF-1↓, VEGF↓, TumCI↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Migration ⓘ

TumCI↓, 1,

Angiogenesis & Vasculature ⓘ

HIF-1↓, 1, Hif1a↓, 1, VEGF↓, 1,
Total Targets: 4

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: TumCI, Tumor Cell invasion

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:170  Target#:324  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid